Haruna Arai

Ehime University

Papers

1

Total Citations

4

H-Index

1

About

Haruna Arai is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer, particularly through robotic-assisted radical prostatectomy. Her most impactful work challenges conventional wisdom by demonstrating that extended pelvic lymph node dissection (ePLND) may not provide a therapeutic benefit for patients with intermediate-to high-risk prostate cancer, a finding with significant implications for reducing surgical morbidity. This landmark 2025 study, already garnering 4 citations, critically evaluates whether lymph node dissection improves biochemical recurrence rates, contributing to the ongoing debate about precision in cancer surgery. Arai’s research sits at the intersection of surgical technique and evidence-based oncology, helping to refine treatment protocols for aggressive prostate cancers. Her work is essential reading for surgeons and oncologists seeking to balance oncologic control with quality of life, and her findings are shaping contemporary guidelines on lymph node management in robotic prostatectomy.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Extended Lymph Node Dissection May Not Provide a Therapeutic Benefit in Patients with Intermediate-to High-Risk Prostate Cancer Treated with Robotic-Assisted Radical Prostatectomy
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Ehime University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago